Literature DB >> 21672485

Moving beyond ineffective medication for OAB.

Stephen S Steele1.   

Abstract

Entities:  

Year:  2011        PMID： 21672485      PMCID： PMC3114033          DOI： 10.5489/cuaj.11083

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  7 in total

Review 1.  Repeat botulinum toxin-A injections for treatment of adult detrusor overactivity.

Authors:  Christopher Dowson; Mohammad Shamim Khan; Prokar Dasgupta; Arun Sahai
Journal:  Nat Rev Urol       Date:  2010-12       Impact factor: 14.432

2.  Botulinum toxin A should not be first-line therapy for overactive bladder.

Authors:  Lesley K Carr
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

3.  Botulinum toxin A: First-line therapy for idiopathic detrusor overactivity.

Authors:  Stephen S Steele
Journal:  Can Urol Assoc J       Date:  2011-06       Impact factor: 1.862

4.  Efficacy and safety of onabotulinumtoxinA for idiopathic overactive bladder: a double-blind, placebo controlled, randomized, dose ranging trial.

Authors:  Roger Dmochowski; Christopher Chapple; Victor W Nitti; Michael Chancellor; Karel Everaert; Catherine Thompson; Grace Daniell; Jihao Zhou; Cornelia Haag-Molkenteller
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

5.  Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.

Authors:  Arun Sahai; Christopher Dowson; Mohammad S Khan; Prokar Dasgupta
Journal:  BJU Int       Date:  2009-04-15       Impact factor: 5.588

6.  Clean intermittent self-catheterization after botulinum neurotoxin type A injections: short-term effect on quality of life.

Authors:  Thomas M Kessler; Shahid Khan; Jalesh Panicker; Alexander Roosen; Sohier Elneil; Clare J Fowler
Journal:  Obstet Gynecol       Date:  2009-05       Impact factor: 7.661

7.  Overactive bladder medication adherence when medication is free to patients.

Authors:  Christine L G Sears; Christa Lewis; Kathleen Noel; Todd S Albright; John R Fischer
Journal:  J Urol       Date:  2010-01-21       Impact factor: 7.450
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.